Literature DB >> 8852696

Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats.

C Förster1, K Kociok, M Shakibaei, H J Merker, J Vormann, T Günther, R Stahlmann.   

Abstract

Recently, we showed that magnesium deficiency induces lesions in knee joint cartilage from 5-week-old rats that are very similar to ofloxacin-induced cartilage defects. We concluded that quinolone-induced arthropathy is probably due to chelation of magnesium and thus a deficit in functionally available magnesium in joint cartilage (Stahlmann et al. 1995). As magnesium deficiency in joint cartilage could impair chondrocyte-matrix interaction which is mediated by cation-dependent integrin receptors of the beta 1-subfamily, we investigated integrin expression in joint cartilage from untreated, ofloxacin-treated and magnesium-deficient Wistar rats. With immunohistochemical methods using monoclonal and polyclonal antibodies, we showed that the integrin pattern in joint cartilage from rats corresponded largely to integrin expression described for human cartilage tissue: beta 1, alpha 1, alpha 3 and alpha v subunits and the alpha 5 beta 1 and alpha v beta 3 heterodimers were consistently expressed. Joint cartilage lesions were detected in ofloxacin-treated and magnesium-deficient rats. Lesions were more pronounced in the quinolone-treated group. Expression of several integrins was reduced in the vicinity of lesions after oral treatment with 2 x 600 mg ofloxacin/kg for 1 day. Gross-structural lesions (e.g., cleft formation, unmasked collagen fibres) in magnesium-deficient rats were very similar but changes in integrin expression were less pronounced. On the other hand, changes in cartilage matrix composition showed similar alterations in ofloxacin-treated and magnesium-deficient rats: fibronectin deposition in the cartilage matrix increased in both groups while glycosaminoglycan content decreased. In summary, similar defects occur in ofloxacin-treated and magnesium-deficient rats and with immunohistochemical methods subtle differences are demonstrable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852696     DOI: 10.1007/s002040050272

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.

Authors:  M Shakibaei; K Pfister; R Schwabe; J Vormann; R Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  Role of integrins and their ligands in osteoarthritic cartilage.

Authors:  Jian Tian; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2014-09-27       Impact factor: 2.631

3.  Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice.

Authors:  M A Simonin; P Gegout-Pottie; A Minn; P Gillet; P Netter; B Terlain
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.

Authors:  Edith Lozo; Kai Riecke; Rudolf Schwabe; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.

Authors:  Eva Maria Kappel; Mehdi Shakibaei; Akintunde Bello; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.

Authors:  Yoonhye Kim; Minwoo Paik; Chanjoo Khan; Yae-Jean Kim; EunYoung Kim
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.